Sfoglia per Autore
Tnp-alpha determination in serum and pleural effusion in patients with lung-cancer
1995-01-01 Scagliotti, G; Gatti, E; Ferrari, G; Mutti, L; Pozzi, E
Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung
1995-01-01 Giaccone, G; van Ark-Otte, J; Scagliotti, G; Capranico, G; van der Valk, P; Rubio, G; Dalesio, O; Lopez, R; Zunino, F; Walboomers, J
Preliminary results of a dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer
1996-01-01 Scagliotti, GV; Crinó, L; Pozzi, E; Corgna, E; Palladino, M; Masiero, P; Salsano, V; Gentile, A; Tonato, M
Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients
1996-01-01 Ferrari, G; Scagliotti, GV
Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer.
1996-01-01 SCAGLIOTTI GV ;RICARDI U ;CRINÓ L ;MARANZANO E ;DE MARINIS F ;MORANDI MG ;MEACCI L ;MARANGOLO M ;EMILIANI E ;ROSTI G ;FIGOLI F ;BOLZICCO G ;MASIERO P ;GENTILE A ;TONATO M
Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial
1996-01-01 Postmus, P E; Scagliotti, G; Groen, H J; Gozzelino, F; Burghouts, J T; Curran, D; Sahmoud, T; Kirkpatrick, A; Giaccone, G; Splinter, T A
Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.
1997-01-01 Crinò L; Scagliotti G; Marangolo M; Figoli F; Clerici M; De Marinis F; Salvati F; Cruciani G; Dogliotti L; Pucci F; Paccagnella A; Adamo V; Altavilla G; Incoronato P; Trippetti M; Mosconi AM; Santucci A; Sorbolini S; Oliva C; Tonato M.
Neo-adjuvant chemotherapy prior to surgery in stage III non-small cell lung cancer.
1997-01-01 SCAGLIOTTI GV; FERRARI G; S. NOVELLO
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer
1997-01-01 Giaccone, G; Postmus, P E; Splinter, T A; Diaz-Puente, M; Van Zandwijk, N; Scagliotti, G; Ardizzoni, A; Van Meerbeeck, J; Debruyne, C
Chemotherapy of non-small cell lung cancer
1997-01-01 Scagliotti, GV; Crinò, L
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer
1998-01-01 Giaccone, Giuseppe*; Splinter, Ted A.; Debruyne, Channa; Kho, Gwan S.; Lianes, Pilar; Van Zandwijk, Nico; Pennucci, Maria Cristina; Scagliotti, Giorgio; Van Meerbeeck, Jan; Van Hoesel, Quirinus; Curran, Desmond; Sahmoud, Tarek; Postmus, Piet E.
Radiotherapy with/without cisplatin following chemotherapy in limited small-cell lung cancer [3]
1998-01-01 Scagliotti, Giorgio V.*; Gregor, Anna; Giaccone, Giuseppe
Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial
1998-01-01 Crinò, L; Mosconi, A M; Scagliotti, GV; Selvaggi, G; Rinaldi, M; Della Giulia, M; Gridelli, C; Calandri, C; De Marinis, F; Noseda, M; Tonato, M
Carcinoma polmonare non a piccole cellule.
1998-01-01 S. NOVELLO; SCAGLIOTTI GV
New drugs for new chemotherapy standards.
1999-01-01 SCAGLIOTTI GV; S. NOVELLO
Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project
1999-01-01 Crinò, L.; Scagliotti, Giorgio V.*; Ricci, S.; De Marinis, F.; Rinaldi, M.; Gridelli, C.; Ceribelli, A.; Bianco, R.; Marangolo, M.; Di Costanzo, F.; Sassi, M.; Barni, S.; Ravaioli, A.; Adamo, V.; Portalone, L.; Cruciani, G.; Masotti, A.; Ferrara, G.; Gozzelino, F.; Tonato, M.
Multidrug resistance in non-small cell lung cancer.
1999-01-01 SCAGLIOTTI GV; NOVELLO S, SELVAGGI G
PHASE I/II DOSE FINDING STUDY OF PACLITAXEL AND CARBOPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER.
1999-01-01 SCAGLIOTTI GV; CRINÒ L; POZZI E; CORGNA E; SELVAGGI G; S. NOVELLO; SALSANO G; GENTILE A; PALLADINO M; MARRACOLO F; TONATO M
Gemcitabine as second-line treatment for advanced Non-Small cell lung cancer; a phase II trial.
1999-01-01 CRINÒ L; MOSCONI AM; SCAGLIOTTI G; SELVAGGI G; S. NOVELLO; RINALDI M; DELLA GIULIA M; GRIDELLI C; ROSSI A; CALANDRI C; DE MARINIS F; NOSEDA M; TONATO M
Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer
2000-01-01 Scagliotti, GV
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Tnp-alpha determination in serum and pleural effusion in patients with lung-cancer | 1995 | Scagliotti, G; Gatti, E; Ferrari, G; Mutti, L; Pozzi, E | |
| Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung | 1995 | Giaccone, G; van Ark-Otte, J; Scagliotti, G; Capranico, G; van der Valk, P; Rubio, G; Dalesio, O; Lopez, R; Zunino, F; Walboomers, J | |
| Preliminary results of a dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancer | 1996 | Scagliotti, GV; Crinó, L; Pozzi, E; Corgna, E; Palladino, M; Masiero, P; Salsano, V; Gentile, A; Tonato, M | |
| Serum and urinary vascular endothelial growth factor levels in non-small cell lung cancer patients | 1996 | Ferrari, G; Scagliotti, GV | |
| Phase II study of intensive chemotherapy with carboplatin, ifosfamide and etoposide plus recombinant human granulocyte colony-stimulating factor and sequential radiotherapy in locally advanced, unresectable non-small-cell lung cancer. | 1996 | SCAGLIOTTI GV ;RICARDI U ;CRINÓ L ;MARANZANO E ;DE MARINIS F ;MORANDI MG ;MEACCI L ;MARANGOLO M ;EMILIANI E ;ROSTI G ;FIGOLI F ;BOLZICCO G ;MASIERO P ;GENTILE A ;TONATO M | |
| Standard versus alternating non-cross-resistant chemotherapy in extensive small cell lung cancer: an EORTC Phase III trial | 1996 | Postmus, P E; Scagliotti, G; Groen, H J; Gozzelino, F; Burghouts, J T; Curran, D; Sahmoud, T; Kirkpatrick, A; Giaccone, G; Splinter, T A | |
| Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study. | 1997 | Crinò L; Scagliotti G; Marangolo M; Figoli F; Clerici M; De Marinis F; Salvati F; Cruciani G; Dogliotti L; Pucci F; Paccagnella A; Adamo V; Altavilla G; Incoronato P; Trippetti M; Mosconi AM; Santucci A; Sorbolini S; Oliva C; Tonato M. | |
| Neo-adjuvant chemotherapy prior to surgery in stage III non-small cell lung cancer. | 1997 | SCAGLIOTTI GV; FERRARI G; S. NOVELLO | |
| Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer | 1997 | Giaccone, G; Postmus, P E; Splinter, T A; Diaz-Puente, M; Van Zandwijk, N; Scagliotti, G; Ardizzoni, A; Van Meerbeeck, J; Debruyne, C | |
| Chemotherapy of non-small cell lung cancer | 1997 | Scagliotti, GV; Crinò, L | |
| Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer | 1998 | Giaccone, Giuseppe*; Splinter, Ted A.; Debruyne, Channa; Kho, Gwan S.; Lianes, Pilar; Van Zandwijk, Nico; Pennucci, Maria Cristina; Scagliotti, Giorgio; Van Meerbeeck, Jan; Van Hoesel, Quirinus; Curran, Desmond; Sahmoud, Tarek; Postmus, Piet E. | |
| Radiotherapy with/without cisplatin following chemotherapy in limited small-cell lung cancer [3] | 1998 | Scagliotti, Giorgio V.*; Gregor, Anna; Giaccone, Giuseppe | |
| Gemcitabine as second-line treatment for relapsing or refractory advanced non-small cell lung cancer: a phase II trial | 1998 | Crinò, L; Mosconi, A M; Scagliotti, GV; Selvaggi, G; Rinaldi, M; Della Giulia, M; Gridelli, C; Calandri, C; De Marinis, F; Noseda, M; Tonato, M | |
| Carcinoma polmonare non a piccole cellule. | 1998 | S. NOVELLO; SCAGLIOTTI GV | |
| New drugs for new chemotherapy standards. | 1999 | SCAGLIOTTI GV; S. NOVELLO | |
| Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project | 1999 | Crinò, L.; Scagliotti, Giorgio V.*; Ricci, S.; De Marinis, F.; Rinaldi, M.; Gridelli, C.; Ceribelli, A.; Bianco, R.; Marangolo, M.; Di Costanzo, F.; Sassi, M.; Barni, S.; Ravaioli, A.; Adamo, V.; Portalone, L.; Cruciani, G.; Masotti, A.; Ferrara, G.; Gozzelino, F.; Tonato, M. | |
| Multidrug resistance in non-small cell lung cancer. | 1999 | SCAGLIOTTI GV; NOVELLO S, SELVAGGI G | |
| PHASE I/II DOSE FINDING STUDY OF PACLITAXEL AND CARBOPLATIN IN ADVANCED NON-SMALL CELL LUNG CANCER. | 1999 | SCAGLIOTTI GV; CRINÒ L; POZZI E; CORGNA E; SELVAGGI G; S. NOVELLO; SALSANO G; GENTILE A; PALLADINO M; MARRACOLO F; TONATO M | |
| Gemcitabine as second-line treatment for advanced Non-Small cell lung cancer; a phase II trial. | 1999 | CRINÒ L; MOSCONI AM; SCAGLIOTTI G; SELVAGGI G; S. NOVELLO; RINALDI M; DELLA GIULIA M; GRIDELLI C; ROSSI A; CALANDRI C; DE MARINIS F; NOSEDA M; TONATO M | |
| Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer | 2000 | Scagliotti, GV |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile